- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Canadian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
1
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ACB | CA$6.15 | 0% | -3.9% | CA$337.3m | CA$8.75 | PS1.1x | E133.0% | n/a |
Page 1 of 1